Patent · US Active

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

US8632782B2 · kind B2 · utility

9Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2011
Grant dateJan 21, 2014
Priority date—
Expiry dateSep 22, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features novel attenuated dengue virus mutants and compositions thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.